{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:58:30Z","timestamp":1790639910296,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3M2141 and CORPG3P0181"],"award-info":[{"award-number":["CMRPG3M2141 and CORPG3P0181"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04777-3","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:43:56Z","timestamp":1790592236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for recurrent urinary tract infection after SGLT2 inhibitor reinitiation in type 2 diabetes"],"prefix":"10.1007","volume":"91","author":[{"given":"Yu-Chu","family":"Hsueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9297-6320","authenticated-orcid":false,"given":"Yi-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"22","key":"4777_CR1","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"B. Zinman, C. Wanner, J.M. Lachin, D. Fitchett, E. Bluhmki, S. Hantel et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373(22), 2117\u20132128 (2015). https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"4777_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"S.D. Wiviott, I. Raz, M.P. Bonaca, O. Mosenzon, E.T. Kato, A. Cahn et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 380(4), 347\u2013357 (2019). https:\/\/doi.org\/10.1056\/NEJMoa1812389","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"4777_CR3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"H.J.L. Heerspink, B.V. Stefansson, R. Correa-Rotter, G.M. Chertow, T. Greene, F.F. Hou et al. Dapagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 383(15), 1436\u20131446 (2020). https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"4777_CR4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"V. Perkovic, M.J. Jardine, B. Neal, S. Bompoint, H.J.L. Heerspink, D.M. Charytan et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380(24), 2295\u20132306 (2019). https:\/\/doi.org\/10.1056\/NEJMoa1811744","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"4777_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"The EMPA-KIDNEY Collaborative Group, W.G. Herrington, N. Staplin, C. Wanner, J.B. Green, S.J. Hauske et al. Empagliflozin in Patients with Chronic Kidney Disease. N. Engl. J. Med. 388(2), 117\u2013127 (2023). https:\/\/doi.org\/10.1056\/NEJMoa2204233","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"4777_CR6","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jacc.2024.01.040","volume":"83","author":"V Kittipibul","year":"2024","unstructured":"V. Kittipibul, Z.L. Cox, S. Chesdachai, M. Fiuzat, J. Lindenfeld, R.J. Mentz, Genitourinary tract infections in patients taking SGLT2 inhibitors: JACC review topic of the week. J. Am. Coll. Cardiology 83(16), 1568\u20131578 (2024). https:\/\/doi.org\/10.1016\/j.jacc.2024.01.040","journal-title":"J. Am. Coll. Cardiology"},{"issue":"3","key":"4777_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diabres.2013.12.052","volume":"103","author":"S Geerlings","year":"2014","unstructured":"S. Geerlings, V. Fonseca, D. Castro-Diaz, J. List, S. Parikh, Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria. Diabetes Res. Clin. Pract. 103(3), 373\u2013381 (2014). https:\/\/doi.org\/10.1016\/j.diabres.2013.12.052","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"4777_CR8","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/jcm14061960","volume":"14","author":"LG Confederat","year":"2025","unstructured":"L.G. Confederat, O.M. Dragostin, M.I. Condurache, SGLT2 inhibitors and the risk of urogenital infections: a concise review. J. Clin. Med. 14(6), 1960 (2025). https:\/\/doi.org\/10.3390\/jcm14061960","journal-title":"J. Clin. Med."},{"issue":"12","key":"4777_CR9","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/j.clinthera.2016.11.002","volume":"38","author":"RM Goldenberg","year":"2016","unstructured":"R.M. Goldenberg, L.D. Berard, A.Y.Y. Cheng, J.D. Gilbert, S. Verma, V.C. Woo et al. SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis. Clin. Ther. 38(12), 2654\u201364.e1 (2016). https:\/\/doi.org\/10.1016\/j.clinthera.2016.11.002","journal-title":"Clin. Ther."},{"key":"4777_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bone.2015.04.026","volume":"82","author":"C Meier","year":"2016","unstructured":"C. Meier, A.V. Schwartz, A. Egger, B. Lecka-Czernik, Effects of diabetes drugs on the skeleton. Bone 82, 93\u2013100 (2016). https:\/\/doi.org\/10.1016\/j.bone.2015.04.026","journal-title":"Bone"},{"issue":"5","key":"4777_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/dom.13647","volume":"21","author":"JY Yang","year":"2019","unstructured":"J.Y. Yang, T. Wang, V. Pate, E.W. Gower, M.J. Crowley, J.B. Buse et al. Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: evolving questions, evolving answers. Diabetes Obes. Metab. 21(5), 1223\u20131236 (2019). https:\/\/doi.org\/10.1111\/dom.13647","journal-title":"Diabetes Obes. Metab."},{"key":"4777_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/dmso.S51792","volume":"8","author":"O Nitzan","year":"2015","unstructured":"O. Nitzan, M. Elias, B. Chazan, W. Saliba, Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab. Syndr. Obes. 8, 129\u2013136 (2015). https:\/\/doi.org\/10.2147\/dmso.S51792","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"4777_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3588297","volume":"2022","author":"S Paudel","year":"2022","unstructured":"S. Paudel, P.P. John, S.L. Poorbaghi, T.M. Randis, R. Kulkarni, Systematic review of literature examining bacterial urinary tract infections in diabetes. J. Diabetes Res. 2022, 3588297 (2022). https:\/\/doi.org\/10.1155\/2022\/3588297","journal-title":"J. Diabetes Res."},{"issue":"2","key":"4777_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/medicina61020202","volume":"61","author":"IC Liang","year":"2025","unstructured":"I.C. Liang, H.H. Chang, Y.J. Lai, C.M. Chan, C.H. Sung, C.M. Pu et al. Update on the efficacy and safety of sodium-glucose Co-Transporter 2 inhibitors in patients with chronic diseases: a systematic review and meta-analysis. Medicina 61(2), 202 (2025). https:\/\/doi.org\/10.3390\/medicina61020202","journal-title":"Medicina"},{"key":"4777_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109816","volume":"186","author":"YH Lin","year":"2022","unstructured":"Y.H. Lin, C.H. Lin, Y.Y. Huang, A.S. Tai, S.C. Fu, S.T. Chen et al. Risk factors of first and recurrent genitourinary tract infection in patients with type 2 diabetes treated with SGLT2 inhibitors: a retrospective cohort study. Diabetes Res. Clin. Pract. 186, 109816 (2022). https:\/\/doi.org\/10.1016\/j.diabres.2022.109816","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"13","key":"4777_CR16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/circulationaha.123.065748","volume":"148","author":"M Packer","year":"2023","unstructured":"M. Packer, J. Butler, C. Zeller, S.J. Pocock, M. Brueckmann, J.P. Ferreira et al. Blinded withdrawal of long-term randomized treatment with empagliflozin or placebo in patients with heart failure. Circulation 148(13), 1011\u20131022 (2023). https:\/\/doi.org\/10.1161\/circulationaha.123.065748","journal-title":"Circulation"},{"issue":"11","key":"4777_CR17","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.34067\/kid.0005722022","volume":"3","author":"N Wiegley","year":"2022","unstructured":"N. Wiegley, P.N. So, Sodium-glucose cotransporter 2 inhibitors and urinary tract infection: is there room for real concern? Kidney360 3(11), 1991\u20131993 (2022). https:\/\/doi.org\/10.34067\/kid.0005722022","journal-title":"Kidney360"},{"key":"4777_CR18","doi-asserted-by":"publisher","unstructured":"P.D. Tamma, S.L. Aitken, R.A. Bonomo, A.J. Mathers, D. van Duin, C.J. Clancy Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections. Clin. Infect. Dis.. (2023). https:\/\/doi.org\/10.1093\/cid\/ciad428.","DOI":"10.1093\/cid\/ciad428"},{"issue":"1","key":"4777_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","volume":"86","author":"J Kranz","year":"2024","unstructured":"J. Kranz, R. Bartoletti, F. Bruyere, T. Cai, S. Geerlings, B. Koves et al. European association of urology guidelines on urological infections: summary of the 2024 guidelines. Eur. Urol. 86(1), 27\u201341 (2024). https:\/\/doi.org\/10.1016\/j.eururo.2024.03.035","journal-title":"Eur. Urol."},{"issue":"2","key":"4777_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/JU.0000000000000296","volume":"202","author":"J Anger","year":"2019","unstructured":"J. Anger, U. Lee, A.L. Ackerman, R. Chou, B. Chughtai, J.Q. Clemens et al. Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline. J. Urol. 202(2), 282\u2013289 (2019). https:\/\/doi.org\/10.1097\/JU.0000000000000296","journal-title":"J. Urol."},{"issue":"9","key":"4777_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604\u2013612 (2009). https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"4777_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/medicines9120059","volume":"9","author":"S Uitrakul","year":"2022","unstructured":"S. Uitrakul, K. Aksonnam, P. Srivichai, S. Wicheannarat, S. Incomenoy, The incidence and risk factors of urinary tract infection in patients with type 2 diabetes mellitus using SGLT2 inhibitors: a real-world observational study. Medicines 9(12), 59 (2022). https:\/\/doi.org\/10.3390\/medicines9120059","journal-title":"Medicines"},{"key":"4777_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.maturitas.2021.06.003","volume":"150","author":"M Kang","year":"2021","unstructured":"M. Kang, K.N. Heo, Y.M. Ah, B.R. Yang, J.Y. Lee, Age- and sex-specific risk of urogenital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: a population-based self-controlled case-series study. Maturitas 150, 30\u201336 (2021). https:\/\/doi.org\/10.1016\/j.maturitas.2021.06.003","journal-title":"Maturitas"},{"issue":"5","key":"4777_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41385-022-00549-0","volume":"15","author":"L Deltourbe","year":"2022","unstructured":"L. Deltourbe, L. Lacerda Mariano, T.N. Hreha, D.A. Hunstad, M.A. Ingersoll, The impact of biological sex on diseases of the urinary tract. Mucosal Immunol. 15(5), 857\u2013866 (2022). https:\/\/doi.org\/10.1038\/s41385-022-00549-0","journal-title":"Mucosal Immunol."},{"issue":"8","key":"4777_CR25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67590","volume":"16","author":"MH Bhat","year":"2024","unstructured":"M.H. Bhat, M.S. Baba, M.E. Alam, A.H. Bhat, S. Mir, B.Q. Dar et al. Gender differences in the clinical profile of sodium-glucose Cotransporter-2 Inhibitor-related urinary tract infections. Cureus 16(8), e67590 (2024). https:\/\/doi.org\/10.7759\/cureus.67590","journal-title":"Cureus"},{"issue":"10","key":"4777_CR26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/medicina59101747","volume":"59","author":"LG Confederat","year":"2023","unstructured":"L.G. Confederat, M.I. Condurache, R.E. Alexa, O.M. Dragostin, Particularities of urinary tract infections in diabetic patients: a concise review. Medicina 59(10), 1747 (2023). https:\/\/doi.org\/10.3390\/medicina59101747","journal-title":"Medicina"},{"issue":"12","key":"4777_CR27","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s40264-020-01010-6","volume":"43","author":"TY Milder","year":"2020","unstructured":"T.Y. Milder, S.L. Stocker, R.O. Day, J.R. Greenfield, Potential safety issues with use of sodium-glucose Cotransporter 2 Inhibitors, particularly in people with type 2 diabetes and chronic kidney disease. Drug. Saf. 43(12), 1211\u20131221 (2020). https:\/\/doi.org\/10.1007\/s40264-020-01010-6","journal-title":"Drug. Saf."},{"key":"4777_CR28","doi-asserted-by":"publisher","first-page":"Doc07","DOI":"10.3205\/id000076","volume":"9","author":"JE Scherberich","year":"2021","unstructured":"J.E. Scherberich, R. F\u00fcnfst\u00fcck, K.G. Naber, Urinary tract infections in patients with renal insufficiency and dialysis - epidemiology, pathogenesis, clinical symptoms, diagnosis and treatment. GMS Infect. Dis. 9, Doc07 (2021). https:\/\/doi.org\/10.3205\/id000076","journal-title":"GMS Infect. Dis."},{"issue":"1","key":"4777_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01588-5","volume":"7","author":"B Spaetgens","year":"2017","unstructured":"B. Spaetgens, F. de Vries, J.H.M. Driessen, H.G. Leufkens, P.C. Souverein, A. Boonen et al. Risk of infections in patients with gout: a population-based cohort study. Sci. Rep. 7(1), 1429 (2017). https:\/\/doi.org\/10.1038\/s41598-017-01588-5","journal-title":"Sci. Rep."},{"issue":"5","key":"4777_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1172\/jci105579","volume":"46","author":"SE Malawista","year":"1967","unstructured":"S.E. Malawista, P.T. Bodel, The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes. J. Clin. Invest. 46(5), 786\u2013796 (1967). https:\/\/doi.org\/10.1172\/jci105579","journal-title":"J. Clin. Invest."},{"issue":"4","key":"4777_CR31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.5935\/abc.20180037","volume":"110","author":"JN Cardoso","year":"2018","unstructured":"J.N. Cardoso, C.H. Del Carlo, M.T. Oliveira Junior, M.E. Ochiai, R. Kalil Filho, A.C.P. Barretto, Infection in patients with decompensated heart failure: in-hospital mortality and outcome. Arq. Bras. Cardiol. 110(4), 364\u2013370 (2018). https:\/\/doi.org\/10.5935\/abc.20180037","journal-title":"Arq. Bras. Cardiol."},{"key":"4777_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/717094","volume":"2015","author":"CY Hsiao","year":"2015","unstructured":"C.Y. Hsiao, H.Y. Yang, C.H. Chang, H.L. Lin, C.Y. Wu, M.C. Hsiao et al. Risk factors for development of septic shock in patients with urinary tract infection. Biomed. Res. Int. 2015, 717094 (2015). https:\/\/doi.org\/10.1155\/2015\/717094","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"4777_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40266-013-0145-1","volume":"31","author":"C Tannenbaum","year":"2014","unstructured":"C. Tannenbaum, K. Johnell, Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence. Drugs Aging 31(2), 93\u2013101 (2014). https:\/\/doi.org\/10.1007\/s40266-013-0145-1","journal-title":"Drugs Aging"},{"issue":"8","key":"4777_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jiac.2023.04.019","volume":"29","author":"J Kamei","year":"2023","unstructured":"J. Kamei, T. Fujimura, Urinary tract infection in patients with lower urinary tract dysfunction. J. Infect. Chemother. 29(8), 744\u2013748 (2023). https:\/\/doi.org\/10.1016\/j.jiac.2023.04.019","journal-title":"J. Infect. Chemother."},{"issue":"6","key":"4777_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/pra.0000000000000105","volume":"21","author":"JH Chae","year":"2015","unstructured":"J.H. Chae, B.J. Miller, Beyond Urinary Tract Infections (UTIs) and delirium: a systematic review of UTIs and neuropsychiatric disorders. J. Psychiatr. Pract. 21(6), 402\u2013411 (2015). https:\/\/doi.org\/10.1097\/pra.0000000000000105","journal-title":"J. Psychiatr. Pract."},{"key":"4777_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0924-9338(13)75926-1","volume":"28","author":"EM Stantiford","year":"2013","unstructured":"E.M. Stantiford, N. Echeverr\u00eda Hern\u00e1ndez, F. De la Torre Brasas, O. Pecero Garc\u00eda, A. Duque Dom\u00ednguez, M.M. L\u00e1zaro Redondo et al. 698 \u2013 urinary tract infection and mental illness. Eur. Psychiatry 28, 1 (2013). https:\/\/doi.org\/10.1016\/S0924-9338(13)75926-1","journal-title":"Eur. Psychiatry"},{"key":"4777_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2024.111599","volume":"178","author":"X Zhang","year":"2024","unstructured":"X. Zhang, L. Ma, J. Li, W. Zhang, Y. Xie, Y. Wang, Mental health and lower urinary tract symptoms: results from the NHANES and Mendelian randomization study. J. Psychosom. Res. 178, 111599 (2024). https:\/\/doi.org\/10.1016\/j.jpsychores.2024.111599","journal-title":"J. Psychosom. Res."},{"issue":"10","key":"4777_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100753","volume":"3","author":"ML Neugent","year":"2022","unstructured":"M.L. Neugent, A. Kumar, N.V. Hulyalkar, K.C. Lutz, V.H. Nguyen, J.L. Fuentes et al. Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome. Cell Rep. Med. 3(10), 100753 (2022). https:\/\/doi.org\/10.1016\/j.xcrm.2022.100753","journal-title":"Cell Rep. Med."},{"issue":"4","key":"4777_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40801-024-00465-8","volume":"11","author":"S Uekusa","year":"2024","unstructured":"S. Uekusa, K. Mogi, Y. Ota, Y. Hanai, K. Kitagawa, T. Yoshio et al. A pharmacovigilance study on psychotropic agent-induced urinary retention using the japanese adverse drug event report database. Drugs - Real. World Outcomes 11(4), 691\u2013700 (2024). https:\/\/doi.org\/10.1007\/s40801-024-00465-8","journal-title":"Drugs - Real. World Outcomes"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04777-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:03:20Z","timestamp":1790636600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04777-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4777"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04777-3","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the IRB of Chang Gung Memorial Hospital and the consent was waived. The IRB number is 201601355B0. The requirement for informed consent to participate was waived by the IRB because the data were de-identified and analyzed retrospectively.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"317"}}